Coloplast AS (COLO B) - Product Pipeline Analysis, 2024 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	49 Pages	GlobalData	May, 2024	GBDT18861587

Best Price Guarantee
Price	from $750
Length	49 Pages
Publisher	GlobalData
Published Date	May, 2024
SKU	GBDT18861587

Coloplast AS (COLO B) - Product Pipeline Analysis, 2024 Update

Summary

Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, respiratory, urology care, continence care, and skin and wound care. Its major products include urisheaths, ostomy bags, urine bags, catheters, anal irrigation systems, sling products, advanced foam dressings and hydrocolloid dressings for protection of skin and pressure injuries, cleansers, moisturizers, skin protectants, anti-fungal, and hand cleansers. The company offers its products under several brands, including SenSura, SpeediCath, Persiteen, Biatain, Conveen, InterDry, Brava, and Comfeel. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers, and retailers in Europe, Africa, South America, UAE, Singapore, Asia, Russia, Australia and North America. Coloplast is headquartered in Humlebaek, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Coloplast AS
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Coloplast A/S Company Overview: Coloplast A/S Company Snapshot; Coloplast A/S Pipeline Products and Ongoing Clinical Trials Overview; Coloplast A/S – Pipeline Analysis Overview; Business Description; Coloplast A/S - Key Facts; Coloplast A/S - Major Products and Services; Coloplast A/S Pipeline Products by Development Stage; Coloplast A/S Ongoing Clinical Trials by Trial Status; Coloplast A/S Pipeline Products Overview; Biomedical Implant - Pelvic Organ Prolapse; Biomedical Implant - Pelvic Organ Prolapse Product Overview; CP308 Digital Ostomy Tool; CP308 Digital Ostomy Tool Product Overview; INTIBIA Implantable Tibial Nerve Stimulator; INTIBIA Implantable Tibial Nerve Stimulator Product Overview; INTIBIA Implantable Tibial Nerve Stimulator Clinical Trial; Kerecis Omega3 - Battlefield Wounds; Kerecis Omega3 - Battlefield Wounds Product Overview; Kerecis Omega3 - Third-Degree Burns; Kerecis Omega3 - Third-Degree Burns Product Overview; Kerecis Omega3 Dura; Kerecis Omega3 Dura Product Overview; Kerecis Omega3 Hernia; Kerecis Omega3 Hernia Product Overview; Kerecis Omega3 Viruxide System; Kerecis Omega3 Viruxide System Product Overview; Kerecis Omega3 Viruxide System Clinical Trial; Luja; Luja Product Overview; Ostomy Platform; Ostomy Platform Product Overview; Restorelle DirectFix Anterior Mesh; Restorelle DirectFix Anterior Mesh Product Overview; Restorelle DirectFix Anterior Mesh Clinical Trial; SenSura Mio Convex Soft With Flex Coupling; SenSura Mio Convex Soft With Flex Coupling Product Overview; Sensuro Mio Stoma Baseplat; Sensuro Mio Stoma Baseplat Product Overview; Single-Use Compact Female Intermittent Catheter; Single-Use Compact Female Intermittent Catheter Product Overview; Coloplast A/S - Key Competitors; Coloplast A/S - Key Employees; Coloplast A/S - Key Employee Biographies; Coloplast A/S - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Recent Developments; Coloplast A/S, Recent Developments; May 14, 2024: Kerecis to Present Scientific and Clinical Updates on Fish-Skin Grafts at the Symposium on Advanced Wound Care Spring; May 14, 2024: Coloplast expands its Luja portfolio with next generation catheter for women; May 07, 2024: Coloplast strengthens ostomy care portfolio with three significant product launches; May 01, 2024: Kerecis to Provide Multiple Updates on its Medical-Fish-Skin Technology at the European Wound Management Association Meeting; Apr 30, 2024: Coloplast Receives 510(K) Clearance For Folysil Silicone Catheter; Apr 01, 2024: Coloplast Receives FDA 510(k) Clearance for Biatain Fiber Ag; Feb 15, 2024: Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range; Feb 09, 2024: Coloplast Announces Interim Financial Report, Q1 2023/24; Nov 09, 2023: Coloplast Reports Annual Report 2022/23; Nov 03, 2023: Clinical Consensus on Kerecis Fish-Skin Grafts to Be Presented at the SAWC Wound Conference
Appendix: Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: Coloplast A/S Pipeline Products and Ongoing Clinical Trials Overview; Table 2: Coloplast A/S Pipeline Products by Equipment Type; Table 3: Coloplast A/S Pipeline Products by Indication; Table 4: Coloplast A/S, Key Facts; Table 5: Coloplast A/S, Major Products and Services; Table 6: Coloplast A/S Number of Pipeline Products by Development Stage; Table 7: Coloplast A/S Pipeline Products Summary by Development Stage; Table 8: Coloplast A/S Ongoing Clinical Trials by Trial Status; Table 9: Coloplast A/S Ongoing Clinical Trials Summary; Table 10: Biomedical Implant - Pelvic Organ Prolapse - Product Status; Table 11: Biomedical Implant - Pelvic Organ Prolapse - Product Description; Table 12: CP308 Digital Ostomy Tool - Product Status; Table 13: CP308 Digital Ostomy Tool - Product Description; Table 14: INTIBIA Implantable Tibial Nerve Stimulator - Product Status; Table 15: INTIBIA Implantable Tibial Nerve Stimulator - Product Description; Table 16: INTIBIA Implantable Tibial Nerve Stimulator - A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024); Table 17: Kerecis Omega3 - Battlefield Wounds - Product Status; Table 18: Kerecis Omega3 - Battlefield Wounds - Product Description; Table 19: Kerecis Omega3 - Third-Degree Burns - Product Status; Table 20: Kerecis Omega3 - Third-Degree Burns - Product Description; Table 21: Kerecis Omega3 Dura - Product Status; Table 22: Kerecis Omega3 Dura - Product Description; Table 23: Kerecis Omega3 Hernia - Product Status; Table 24: Kerecis Omega3 Hernia - Product Description; Table 25: Kerecis Omega3 Viruxide System - Product Status; Table 26: Kerecis Omega3 Viruxide System - Product Description; Table 27: Kerecis Omega3 Viruxide System - Study Evaluate the Efficacy of Kerecis Omega3 Viruxide System in COVID-19 Subjects; Table 28: Luja - Product Status; Table 29: Luja - Product Description; Table 30: Ostomy Platform - Product Status; Table 31: Ostomy Platform - Product Description; Table 32: Restorelle DirectFix Anterior Mesh - Product Status; Table 33: Restorelle DirectFix Anterior Mesh - Product Description; Table 34: Restorelle DirectFix Anterior Mesh - Real-Life Use of Transabdominal Restorelle Meshes in Apical Prolapse Repair: an Observational Post-Market Clinical Study; Table 35: SenSura Mio Convex Soft With Flex Coupling - Product Status; Table 36: SenSura Mio Convex Soft With Flex Coupling - Product Description; Table 37: Sensuro Mio Stoma Baseplat - Product Status; Table 38: Sensuro Mio Stoma Baseplat - Product Description; Table 39: Single-Use Compact Female Intermittent Catheter - Product Status; Table 40: Single-Use Compact Female Intermittent Catheter - Product Description; Table 41: Coloplast A/S, Key Employees; Table 42: Coloplast A/S, Key Employee Biographies; Table 43: Coloplast A/S, Subsidiaries; Table 44: Glossary
List of Figures: Figure 1: Coloplast A/S Pipeline Products by Equipment Type; Figure 2: Coloplast A/S Pipeline Products by Development Stage; Figure 3: Coloplast A/S Ongoing Clinical Trials by Trial Status